`
`IPR2019-00400
`Patent 8,633,194
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`APOTEX INC.
`Petitioner,
`
`v.
`
`UCB BIOPHARMA SPRL,
`Patent Owner.
`______________
`
`Case IPR2019-00400
`Patent 8,633,194
`______________
`
`
`PATENT OWNER’S MOTION TO SEAL AND FOR ENTRY OF A
`PROTECTIVE ORDER PURSUANT TO 37 C.F.R. § 42.54
`
`
`
`
`
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194
`Patent Owner UCB Biopharma Sprl hereby moves for entry of the Protective
`
`
`
`Order appended as Addendum A and further moves to seal Exhibit 3005, which
`
`contains Patent Owner’s confidential information. Patent Owner has concurrently
`
`with this motion filed a redacted, non-confidential version of Exhibit 3005
`
`(EX2008), which Patent Owner consents may be made available on the public
`
`docket.
`
`Patent Owner and Petitioner have discussed this Motion, and Petitioner does
`
`not oppose this Motion.
`
`I. MOTION TO SEAL
`Patent Owner moves to seal Exhibit 3005. Exhibit 3005 is an email sent on
`
`July 24, 2019 by counsel for Patent Owner, Robert Counihan, to the Board providing
`
`certain information requested by the Board in its July 15, 2019 Decision on
`
`Institution of Inter Partes Review of U.S. Patent No. 8,633,194 B2 (IPR2019-00400,
`
`Paper 17). In particular, Exhibit 3005 discloses the nature of the relationship
`
`between Patent Owner and Sanofi-Aventis with respect to the patent subject to this
`
`proceeding and the product Xyzal 24HR®. As reflected in the redacted version of
`
`Exhibit 3005 that Patent Owner has provided with this Motion, Patent Owner
`
`respectfully requests that only the portion of Exhibit 3005 that addresses this
`
`relationship be maintained under seal.
`
`The standard for granting a motion to seal is “for good cause.” 37 C.F.R.
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194
`§ 42.54. Good cause exists here because the nature of the relationship between
`
`
`
`Patent Owner and Sanofi-Aventis is competitively-sensitive, non-public, business
`
`information that is itself subject to confidentiality obligations between Patent Owner
`
`and Sanofi-Aventis. See, e.g. Westinghouse Air Brake Techs. Corp. v. Siemens
`
`Mobility, Inc., IPR2017-01669, Paper 60 (PTAB Jan. 8, 2019) (granting motion to
`
`seal similar information). Moreover, the strong public policy for making all
`
`information filed in inter partes review proceedings available to the public should
`
`not apply here because the information that Patent Owner requests to keep
`
`confidential does not relate to the patentability of claims in an issued patent or
`
`otherwise affect the rights of the public.
`
`II. MOTION FOR ENTRY OF A PROTECTIVE ORDER
`Pursuant to 37 CFR § 42.54(a), a motion to seal must be accompanied by a
`
`proposed protective order and a certification that the parties have met-and-conferred
`
`regarding the issue. On July 29, 2019, Patent Owner emailed counsel for Petitioner
`
`to notify Petitioner of Patent Owner’s intent to file the present motion and propose
`
`that the parties adopt the Board’s default protective order, which is appended as
`
`Addendum A. Petitioner had no objections to the requests made in this motion.
`
`Patent Owner respectfully requests that the Board’s default protective order be
`
`entered in this proceeding.
`
`-2-
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194
`
`III. CONCLUSION
`For the foregoing reasons, Patent Owner respectfully requests that the Board
`
`grant this motion to seal and entry of a protective order.
`
`
`
`Dated: July 30, 2019
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/s/ James S. Trainor (Electronically signed)
`James S. Trainor, Reg. No. 52,297
`Lead Counsel
`
`Robert E. Counihan, Reg. No. 61,382
`Back-Up Counsel
`
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, NY 10010
`(212) 430-2600
`jtrainor@fenwick.com
`rcounihan@fenwick.com
`
`Erica R. Sutter, Reg. No. 77,450
`801 California Street
`Mountain View, CA 94041
`(650) 988-8500
`esutter@fenwick.com
`
`
`Counsel for Patent Owner UCB Biopharma
`Sprl
`
`
`
`-3-
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on July 30, 2019, the
`
`foregoing document is being served by filing this document through the Patent Trial
`
`and Appeal Board End to End System, as well as by delivering a copy via electronic
`
`mail upon the following counsel of record for the Petitioner:
`
`
`
`
`
`
`
`jitty.malik@kattenlaw.com
`alissa.pacchioli@kattenlaw.com
`joe.janusz@kattenlaw.com
`lance.soderstrom@kattenlaw.com
`
`
`Date: July 30, 2019
`
`
`Respectfully submitted,
`
`/s/ James S. Trainor (Electronically signed)
`James S. Trainor
`Reg. No. 52,297
`Phone: (212) 921-2001
`
`-4-
`
`
`
`
`
`ADDENDUM A
`
`IPR2019-00400
`Patent 8,633,194
`
`Standing Protective Order
`This standing protective order governs the treatment and filing of confidential
`
`information, including documents and testimony.
`
`1.
`
`Confidential information shall be clearly marked “PROTECTIVE ORDER
`
`MATERIAL.”
`
`2.
`
`Access to confidential information is limited to the following individuals
`
`who have executed the acknowledgment appended to this order:
`
`(A) Parties. Persons who are owners of a patent involved in the
`
`proceeding and other persons who are named parties to the proceeding.
`
`(B) Party Representatives. Representatives of record for a party in the
`
`proceeding.
`
`(C) Experts. Retained experts of a party in the proceeding who further
`
`certify in the Acknowledgement that they are not a competitor to any party, or a
`
`consultant for, or employed by, such a competitor with respect to the subject matter of
`
`the proceeding.
`
`(D)
`
`In-house counsel. In-house counsel of a party.
`
`(E) Other Employees of a Party. Employees, consultants, or other
`
`persons performing work for a party, other than in-house counsel and in-house counsel’s
`
`support staff, who sign the Acknowledgement shall be extended access to confidential
`
`information only upon agreement of the parties or by order of the Board upon a motion
`
`-5-
`
`
`
`IPR2019-00400
`Patent 8,633,194
`brought by the party seeking to disclose confidential information to that person. The
`
`
`
`party opposing disclosure to that person shall have the burden of proving that such
`
`person should be restricted from access to confidential information.
`
`(F) The Office. Employees and representatives of the Office who have a
`
`need for access to the confidential information shall have such access without the
`
`requirement to sign an Acknowledgement. Such employees and representatives shall
`
`include the Director, members of the Board and their clerical staff, other support
`
`personnel, court reporters, and other persons acting on behalf of the Office.
`
`(G) Support Personnel. Administrative assistants, clerical staff, court
`
`reporters and other support personnel of the foregoing persons who are reasonably
`
`necessary to assist those persons in the proceeding shall not be required to sign an
`
`Acknowledgement, but shall be informed of the terms and requirements of the Protective
`
`Order by the person they are supporting who receives confidential information.
`
`3.
`
`Persons receiving confidential information shall use reasonable efforts to
`
`maintain the confidentiality of the information, including:
`
`(A) Maintaining such information in a secure location to which
`
`persons not authorized to receive the information shall not have access;
`
`(B) Otherwise using reasonable efforts to maintain the confidentiality
`
`of the information, which efforts shall be no less rigorous than those the recipient
`
`uses to maintain the confidentiality of information not received from the disclosing
`
`party;
`
`-6-
`
`
`
`IPR2019-00400
`Patent 8,633,194
`(C) Ensuring that support personnel of the recipient who have access
`
`
`
`to the confidential information understand and abide by the obligation to maintain the
`
`confidentiality of information received that is designated as confidential; and
`
`(D) Limiting the copying of confidential information to a reasonable
`
`number of copies needed for conduct of the proceeding and maintaining a record of
`
`the locations of such copies.
`
`4.
`
`Persons receiving confidential information shall use the following
`
`procedures to maintain the confidentiality of the information:
`
`(A) Documents and Information Filed With the Board.
`
`(i) A party may file documents or information with the Board
`
`under seal, together with a non-confidential description of the nature of the confidential
`
`information that is under seal and the reasons why the information is confidential and
`
`should not be made available to the public. The submission shall be treated as
`
`confidential and remain under seal, unless, upon motion of a party and after a hearing on
`
`the issue, or sua sponte, the Board determines that the documents or information do not
`
`qualify for confidential treatment.
`
`(ii) Where confidentiality is alleged as to some but not all of the
`
`information submitted to the Board, the submitting party shall file confidential and non-
`
`confidential versions of its submission, together with a Motion to Seal the confidential
`
`version setting forth the reasons why the information redacted from the non-confidential
`
`version is confidential and should not be made available to the public. The non-
`-7-
`
`
`
`IPR2019-00400
`Patent 8,633,194
`confidential version of the submission shall clearly indicate the locations of information
`
`
`
`that has been redacted. The confidential version of the submission shall be filed under
`
`seal. The redacted information shall remain under seal unless, upon motion of a party
`
`and after a hearing on the issue, or sua sponte, the Board determines that some or all of
`
`the redacted information does not qualify for confidential treatment.
`
`(B) Documents and Information Exchanged Among the Parties.
`
`Information designated as confidential that is disclosed to another party during
`
`discovery or other proceedings before the Board shall be clearly marked as
`
`“PROTECTIVE ORDER MATERIAL” and shall be produced in a manner that
`
`maintains its confidentiality.
`
`Standard Acknowledgement of Protective Order. The following form may be
`
`used to acknowledge a protective order and gain access to information covered by the
`
`protective order.
`
`-8-
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`APOTEX INC.
`Petitioner,
`
`v.
`
`UCB BIOPHARMA SPRL,
`Patent Owner.
`______________
`
`Case IPR2019-00400
`Patent 8,633,194
`______________
`
`
`Standard Acknowledgement for Access to Protective Order Material
`
`
`-9-
`
`
`
`IPR2019-00400
`Patent 8,633,194
`Standard Acknowledgment for Access to Protective Order Material
`
`
`
`I
`
`, affirm that I have
`
`read the Protective Order; that I will abide by its terms; that I will use the confidential
`
`information only in connection with this proceeding and for no other purpose; that I
`
`will only allow access to support staff who are reasonably necessary to assist me in
`
`this proceeding; that prior to any disclosure to such support staff I informed or will
`
`inform them of the requirements of the Protective Order; that I am personally
`
`responsible for the requirements of the terms of the Protective Order and I agree to
`
`submit to the jurisdiction of the Office and the United States District Court for the
`
`Eastern District of Virginia for purposes of enforcing the terms of the Protective
`
`Order and providing remedies for its breach.
`
`
`
`
`
`
`
`
`
`[Signature]
`
`
`
`-10-
`
`